<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03049072</url>
  </required_header>
  <id_info>
    <org_study_id>Register</org_study_id>
    <nct_id>NCT03049072</nct_id>
  </id_info>
  <brief_title>Ion Therapy Patient Registry</brief_title>
  <acronym>REGI-MA-002015</acronym>
  <official_title>A Prospective Registry Study to Record Clinical Results and Side Effects of Ion Beam Therapy at MedAustron</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>EBG MedAustron GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>EBG MedAustron GmbH</source>
  <brief_summary>
    <textblock>
      The purpose of the study is the prospective and standardized data collection of patients
      treated with ion therapy at MedAustron.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During and up to 10 years after radiation therapy data regarding tumor control and treatment
      response as well as acute and late toxicities will be collected at regular time intervals.
      Additionally quality of life and sociodemographic status will be assessed in all study
      patients and neurocognitive assessment will be performed in patients undergoing ion radiation
      of the brain.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2017</start_date>
  <completion_date type="Anticipated">December 2030</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Therapy response</measure>
    <time_frame>10 years</time_frame>
    <description>Therapy Response according to RECIST Version 1.1</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall survival</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Progression-free survival</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Local progression-free survival</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cause-specific survival</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Toxicity</measure>
    <time_frame>10 years</time_frame>
    <description>Acute/late toxicity according to CTCAEv4.03, June 14,2010</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>EORTC-QLQ-C30</measure>
    <time_frame>Through study completion, at 3, 5, and 10 years</time_frame>
    <description>Patient-reported quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EORTC-QLQ-BN20</measure>
    <time_frame>Through study completion, at 3, 5, and 10 years</time_frame>
    <description>Patient-reported quality of life for brain cancer patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EORTC-QLQ-PR25</measure>
    <time_frame>Through study completion, at 3, 5, and 10 years</time_frame>
    <description>Patient-reported quality of life for prostate cancer patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurocognitive test battery</measure>
    <time_frame>Through study completion, at 3, 5, and 10 years</time_frame>
    <description>Change in cognition from baseline to endpoint as measured by standardized subtests of test battery</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Ion Beam Radiation Therapy for Tumor Patients</condition>
  <arm_group>
    <arm_group_label>Ion beam therapy</arm_group_label>
    <description>All patients treated with ion beam therapy at MedAustron who consent to the participation in the registry.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Protons and Carbon Ions</intervention_name>
    <arm_group_label>Ion beam therapy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients treated with ion beam therapy at MedAustron
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with tumor disease treated with ion beam therapy at MedAustron

          -  Signed informed consent form

        Exclusion Criteria:

          -  Comorbidities endangering treatment delivery or study compliance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eugen B Hug, Prof. MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>EBG MedAustron GmbH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eugen B Hug, Prof. MD</last_name>
    <phone>+43 2622 26 100</phone>
    <phone_ext>102</phone_ext>
    <email>eugen.hug@medaustron.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Petra Georg, PhD MD</last_name>
    <phone>+43 2622 26 100</phone>
    <phone_ext>356</phone_ext>
    <email>petra.georg@medaustron.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>EBG MedAustron GmbH</name>
      <address>
        <city>Wiener Neustadt</city>
        <state>Nieder√∂sterreich</state>
        <zip>2700</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eugen B Hug, Prof. Dr.</last_name>
      <phone>+43 2622 26 100</phone>
      <phone_ext>102</phone_ext>
      <email>eugen.hug@medaustron.at</email>
    </contact>
    <contact_backup>
      <last_name>Petra Georg, PD Dr.</last_name>
      <phone>+43 2622 26 100</phone>
      <phone_ext>356</phone_ext>
      <email>petra.georg@medaustron.at</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 13, 2017</study_first_submitted>
  <study_first_submitted_qc>February 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2017</study_first_posted>
  <last_update_submitted>March 20, 2018</last_update_submitted>
  <last_update_submitted_qc>March 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

